Differences
This shows you the differences between two versions of the page.
| Next revision | Previous revisionBoth sides next revision |
pharmaceutical_companies:icosavax [2023/03/12 06:48] liam created | pharmaceutical_companies:icosavax [2024/11/02 18:57] (current) liam [External links] |
|---|
| |
| {{ :pharmaceutical_companies:icosavax.png?200|}} | {{ :pharmaceutical_companies:icosavax.png?200|}} |
| | |
| | **Icosavax** is an American biotechnology company based in [[:united_states:washington:Seattle]], [[:united_states:Washington]]. |
| | |
| | ===== History ===== |
| | |
| | Icosavax was founded in 2017 to advance [[:virus-like particle]] (VLP) technology from the [[:Institute for Protein Design]] at the [[:University of Washington]] with the goal to discover, develop, and commercialize [[:vaccines]] against [[:infectious diseases]].((//Corporate profile.// Icosavax. Retrieved March 12, 2023, from http://archive.today/2023.03.12-054948/https://ir.icosavax.com/)) |
| | |
| | ===== Activities ===== |
| | |
| | Icosavax is developing products for [[:SARS-CoV-2]], [[:RSV]] and [[:human metapneumovirus]] (hMPV). |
| | |
| | ===== External links ===== |
| | |
| | * [[https://icosavax.com|Website]] |
| | * [[https://wiki.whiteroseintelligence.com/en/Icosavax|White Rose Wiki]] |